» Articles » PMID: 21333872

Effect of Brimonidine Tartrate 0.10% Ophthalmic Solution on Pupil Diameter

Overview
Specialty Ophthalmology
Date 2011 Feb 22
PMID 21333872
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the effect of brimonidine tartrate 0.10% ophthalmic solution on pupil diameter under light and dark luminance conditions.

Setting: Ophthalmology Department, Tel Aviv Medical Center, Tel Aviv, Israel.

Design: Case series.

Methods: The pupil diameter was measured with a Colvard pupillometer in eyes of healthy volunteers under light (5.0 candelas [cd]/m(2)) and dark (0.0 cd/m(2)) luminance conditions before brimonidine 0.10% instillation and after 30 minutes, 3 hours, and 6 hours.

Results: The mean age of the 26 volunteers (52 eyes) was 34.73 years (range 19 to 60 years). Under light conditions, the mean pupil diameter was 4.98 mm ± 0.83 (SD) before instillation of brimonidine 0.10% and 4.64 ± 0.82 mm after instillation. The difference was not statistically significant, with 13.4% of eyes having a clinically significant reduction (>1.0 mm) in pupil diameter after 6 hours. Under dark conditions, the mean pupil diameter was 6.76 ± 1.08 mm before instillation of brimonidine 0.10% and 5.30 ± 0.85 mm after instillation; the difference was statistically significant (P<.001). There was a clinically significant reduction in pupil diameter after 6 hours in 90.4% of eyes. The antimydriatic effect under dark luminance conditions was more pronounced in eyes with light irides.

Conclusions: Brimonidine 0.10% ophthalmic solution had an antimydriatic effect under dark luminance conditions and had a negligible effect on pupil diameter under light luminance conditions. The effect was similar to that reported in studies using higher concentrations of brimonidine.

Citing Articles

Crossover Randomized Study of Pharmacologic Effects of Ripasudil-Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine.

Tanihara H, Yamamoto T, Aihara M, Koizumi N, Minami H, Kojima S Adv Ther. 2023; 40(8):3559-3573.

PMID: 37330927 PMC: 10329961. DOI: 10.1007/s12325-023-02534-w.


Comparative Analysis of Pupil Diameters in Light and Dark Conditions After Instillation of 0.15% Brimonidine Drops in Eyes With and Without Pseudoexfoliation Syndrome.

Cate S, Bektas C, Turgut B Beyoglu Eye J. 2022; 5(3):209-213.

PMID: 35098090 PMC: 8784457. DOI: 10.14744/bej.2020.52244.


Effects of brimonidine tartrate 0.1% ophthalmic solution on the pupil, refraction, and light reflex.

Kato C, Shimizu K, Kamiya K, Ishikawa H, Igarashi A Sci Rep. 2018; 8(1):9003.

PMID: 29899357 PMC: 5998017. DOI: 10.1038/s41598-018-27436-8.


Clinical outcomes of combined versus separate carbachol and brimonidine drops in correcting presbyopia.

Abdelkader A, Kaufman H Eye Vis (Lond). 2016; 3:31.

PMID: 27981057 PMC: 5139101. DOI: 10.1186/s40662-016-0065-3.


Pre- and postsynaptic effects of brimonidine on isolated rabbit iris dilator muscles.

Tatsui S, Ishikawa H, Shimizu K, Mashimo K Clin Ophthalmol. 2016; 10:845-9.

PMID: 27274189 PMC: 4869645. DOI: 10.2147/OPTH.S100755.